Perceived relative clinical significance of the risks of venous thromboembolism and bleeding from pharmacologic thromboprophylaxis in children: an international survey of pediatric providers: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis
Journal of Thrombosis and Haemostasis · 2026
DOI: 10.1016/j.jtha.2025.12.007 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Robert Marcel T Huibonhoa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Critical Care, Department of Pediatrics, University of Illinois College of Medicine, Peoria, Illinois, USA. Electronic address: huibonhr@…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Hemorrhage, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, International Society on Thrombosis and Haemostasis.
Themen: Thromboseprophylaxe, Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: In the absence of robust data, the decision to provide primary pharmacologic thromboprophylaxis in hospitalized children depends on the perceived risks of hospital-acquired venous thromboembolism (HA-VTE), balanced against the acceptable bleeding risk from thromboprophylaxis. OBJECTIVES: We aimed (1) to determine the perceived relative clinical significance of HA-VTE and bleeding from thromboprophylaxis among pediatric providers, and (2) to determine patient and provider characteristics that modify this perception. METHODS: We conducted a cross-sectional survey among pediatric providers. Using case vignettes and Likert scales, we quantified the likelihood of providing thromboprophylaxis to prevent 4 types of HA-VTE, varying in severity, given equal risks of developing 6 bleeding characteristics, ranging from minor to fatal. We evaluated 9 patient characteristics, including patient age, and 7 provider characteristics that may modify this decision. RESULTS: A median of 145 (IQR, 139-152) respondents answered each vignette. For all bleeding characteristics other than minor bleeding, respondents were less likely to provide thromboprophylaxis to prevent nonsevere HA-VTE, except for pulmonary embolism with hemodynamic compromise. HA-VTE type, bleeding, and patient characteristics, particularly infant age, were associated with a change in scores in the likelihood of providing thromboprophylaxis. However, changes were minimal, with only infant age associated with a change of ≥1 point. CONCLUSION: Among pediatric providers, the acceptable bleeding risk for primary pharmacologic thromboprophylaxis varies with perceived HA-VTE severity. Specific features, particularly infant age, modified the respondents' decisions despite the stated risks. Our findings can provide a robust, semiquantitative approach to address these competing risks clinically and in future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Critical Care, Department of Pediatrics, University of Illinois College of Medicine, Peoria, Illinois, USA. Electronic address: huibonhr@uic.edu.
- Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of Critical Care Medicine, Department of Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
- Department of Anesthesia and Critical Care Medicine, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Bambino Gesù Children's Hospital, Rome, Italy.
- Division of Pediatric Hematology Oncology, Department of Pediatrics, Valerie Fund Children's Center, Atlantic Health System, Goryeb Children's Hospital, Morristown, New Jersey, USA.
- Division of Critical Care, Department of Pediatrics, University of Illinois College of Medicine, Peoria, Illinois, USA.
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- International Society on Thrombosis and Haemostasis
Zitieren
APA
Huibonhoa, R. M. T., Raffini, L., Sochet, A. A., Chiusolo, F., Nossair, F., Tripathi, S., Faustino, E. V. S., & Blood Research Network of the Pediatric Acute Lung Injury and Sepsis Investigators network (2026). Perceived relative clinical significance of the risks of venous thromboembolism and bleeding from pharmacologic thromboprophylaxis in children: an international survey of pediatric providers: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.12.007
Vancouver
Huibonhoa RMT, Raffini L, Sochet AA, Chiusolo F, Nossair F, Tripathi S, et al. Perceived relative clinical significance of the risks of venous thromboembolism and bleeding from pharmacologic thromboprophylaxis in children: an international survey of pediatric providers: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.12.007
BibTeX
@article{Huibonhoa2026,
author = {Huibonhoa, Robert Marcel T and Raffini, Leslie and Sochet, Anthony A and Chiusolo, Fabrizio and Nossair, Fadi and Tripathi, Sandeep and Faustino, E Vincent S and Blood Research Network of the Pediatric Acute Lung Injury and Sepsis Investigators network, Blood Research Network of the Pediatric Acute Lung Injury and Sepsis Investigators network},
title = {Perceived relative clinical significance of the risks of venous thromboembolism and bleeding from pharmacologic thromboprophylaxis in children: an international survey of pediatric providers: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2025.12.007}
}
EUVIMED